Endometriosis has no disease-modifying cure. Every treatment targets the symptoms
Hormones, surgery and painkillers can reduce pain and improve fertility, but none reliably alter the disease itself — and even removing the uterus does not guarantee the disease goes with it.
Endometriosis, which affects an estimated 10% — around 190 million — of reproductive-age women worldwide, has no cure and no treatment that reliably changes the course of the disease itself [s2]. Everything currently offered — hormonal medicines, surgery, painkillers — aims to control symptoms such as pain and infertility, and the World Health Organization states plainly that "no treatments cure the disease" [s2]. Even hysterectomy, the most drastic surgical option, "will not necessarily cure the symptoms or the disease," according to the European guideline [s1].
That is the honest answer to a question patients ask constantly and rarely get straight: is there anything that treats the disease, or only the pain? For now, only the pain and its consequences.
What "symptom control" means in practice
The European Society of Human Reproduction and Embryology (ESHRE) guideline, the most detailed evidence review of endometriosis management, organises treatment around symptoms rather than around eradicating the disease [s1]. It describes endometriosis as "a chronic condition with a plethora of presentations," and its recommendations are built to reduce endometriosis-associated pain and to address infertility [s1].
For pain, it supports non-steroidal anti-inflammatory drugs and other analgesics for symptomatic relief [s1]. It recommends hormonal treatment — combined hormonal contraceptives, progestogens, GnRH agonists or GnRH antagonists — as options to reduce pain, and specifically supports a levonorgestrel-releasing intrauterine system or an etonogestrel-releasing implant for the same purpose [s1]. All of these suppress or manage the disease's activity; none is presented as curing it.
Surgery reduces symptoms and recurs
Surgery can remove visible endometriosis and improve pain and fertility, but the guideline's framing again is symptomatic and its language is shot through with the problem of recurrence [s1]. When operating on an ovarian endometrioma, it recommends removing the cyst wall (cystectomy) rather than draining and coagulating it, because cystectomy "reduces recurrence of endometrioma and endometriosis-associated pain" [s1]. It suggests excising rather than ablating lesions to reduce pain [s1].
The recurrence problem is explicit: cystectomy and laser vaporisation "appear to have similar recurrence rates beyond the first year after surgery," and early recurrence may be lower after cystectomy [s1]. In other words, surgery buys symptom relief that can fade, not a permanent fix — which is why repeat operations are common.
The pregnancy myth
The guideline also dispatches a persistent piece of folk advice: that pregnancy treats endometriosis. Women should be informed that "pregnancy does not always lead to improvement of symptoms or reduction of disease progression" [s1]. Pregnancy may pause symptoms for some, but it is not a treatment, and telling a patient to get pregnant to fix her endometriosis is not supported by the evidence [s1].
Why there is no disease-modifying drug yet
The absence of a curative or disease-modifying therapy is not for lack of interest; it reflects how poorly the disease's fundamental biology is still understood. The WHO notes the cause of endometriosis is unknown and there is no known way to prevent it [s2]. Newer drugs in the class — oral GnRH antagonists, for example — are refinements of hormonal symptom suppression, not agents shown to reverse or halt the disease. Until a treatment demonstrably alters the disease process rather than damping its output, the honest description of the entire toolkit is symptom control.
For patients, the practical implications are real. It means treatment is usually long-term and iterative — trying hormonal options, managing pain, sometimes operating and sometimes operating again — rather than a single definitive intervention [s1]. It means "the disease came back" is an expected feature of the condition, not a treatment failure. And it means claims of a cure, from any quarter, should be read against a global guideline and a WHO fact sheet that both say none exists [s1] [s2].
This article is informational and is not medical advice. Endometriosis care should be individualised with a clinician who can weigh pain, fertility goals and the trade-offs of each option.
Sources
- ESHRE guideline: endometriosis — Human Reproduction Open (ESHRE), 2022-02-26
- Endometriosis (fact sheet) — World Health Organization, 2025-10-15
Sources
- ESHRE guideline: endometriosis — Human Reproduction Open (ESHRE) , February 26, 2022
- Endometriosis (fact sheet) — World Health Organization , October 15, 2025
More on
Premature ovarian insufficiency is rising in Ontario, with endometriosis the top risk
Tracking 3.6 million women over 24 years, researchers found women with endometriosis were nearly 3.5 times more likely to develop the condition before 40. Seventy percent of cases still have no identified cause.
Endometriosis does not always stop at menopause. A European guide says so
An EMAS clinical guide sets out how to manage endometriosis after menopause, advising against oestrogen-only hormone therapy even in women who have had a hysterectomy.
What actually manages PCOS, according to the international guideline
The 2023 global guideline puts lifestyle first for everyone, letrozole first for fertility, and the pill for cycles and excess hair — while rating much of its own evidence low to moderate quality.
The birth control failure rate on the box is the best case, not your case
The numbers most methods advertise are perfect-use figures from clinical trials. In everyday use the pill fails about seven users in 100 a year, the condom about 13, withdrawal about 20.